Prospects for Using Mycophenolate Mofetil in Diffuse Scleroderma

Modern Rheumatology Journal
doi 10.14412/1996-7012-2009-518
Full Text
Abstract

Available in full text

Date
Authors
Publisher

IMA Press, LLC

Related search

Mycophenolate Mofetil for Drug-Induced Vanishing Bile Duct Syndrome

World Journal of Gastroenterology
MedicineGastroenterology
2007English

Editorial: Tailoring Mycophenolate Mofetil Rescue Therapy for Success in Autoimmune Hepatitis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Low Dose of Mycophenolate Mofetil Is Enough in Desensitized Kidney Transplantation Using Rituximab

BMC Nephrology
Nephrology
2015English

Cyclophosphamide Versus Mycophenolate Mofetil for Initial Treatment of Lupus Nephritis

Kidney International
Nephrology
2013English

Mycophenolate Mofetil for Myasthenia Gravis: An Open-Label Pilot Study

Neurology
Neurology
2001English

Is Conversion From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?

Drugs in R and D
Pharmacology
2018English

81 Outcomes of Multi-Target Therapy Using Mycophenolate Mofetil and Tacrolimus for Refractory Lupus Nephritis

2017English

Mycophenolate Mofetil Induced Remission in Steroid-Refractory Autoimmune Hemolytic Anemia

Meandros Medical and Dental Journal
2018English

Mycophenolate Mofetil Reduces STAT3 Phosphorylation in Systemic Lupus Erythematosus Patients

JCI insight
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy